0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Armodafinil Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-31R5732
Home | Market Reports | Health| Pharmacy
Global and United States Armodafinil Market Report Forecast 2022 2028
BUY CHAPTERS

Global Armodafinil Market Insights, Forecast to 2030

Code: QYRE-Auto-31R5732
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Armodafinil Market

Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.
Market Analysis and Insights: Global Armodafinil Market
The global Armodafinil market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Armodafinil is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Armodafinil is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Armodafinil is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Armodafinil include Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma and Aurobindo, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Armodafinil is widely used in various fields, such as Obstructive Sleep Apnea (OSA) and Narcolepsy, Shift Work Disorder (SWD), Patients with Severe Hepatic Impairment and Geriatric Patients, etc. Obstructive Sleep Apnea (OSA) and Narcolepsy provides greatest supports to the Armodafinil industry development. In 2023, global % revenue of Armodafinil went into Obstructive Sleep Apnea (OSA) and Narcolepsy filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Armodafinil market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Armodafinil, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Armodafinil, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Armodafinil revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Armodafinil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Armodafinil revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Armodafinil Market Report

Report Metric Details
Report Name Armodafinil Market
Segment by Type
  • 50 mg Tablets
  • 150 mg Tablets
  • 200 mg Tablets
  • 250 mg Tablets
Segment by Application
  • Obstructive Sleep Apnea (OSA) and Narcolepsy
  • Shift Work Disorder (SWD)
  • Patients with Severe Hepatic Impairment
  • Geriatric Patients
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma, Aurobindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Armodafinil in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Armodafinil companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Armodafinil revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Armodafinil Market report?

Ans: The main players in the Armodafinil Market are Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma, Aurobindo

What are the Application segmentation covered in the Armodafinil Market report?

Ans: The Applications covered in the Armodafinil Market report are Obstructive Sleep Apnea (OSA) and Narcolepsy, Shift Work Disorder (SWD), Patients with Severe Hepatic Impairment, Geriatric Patients

What are the Type segmentation covered in the Armodafinil Market report?

Ans: The Types covered in the Armodafinil Market report are 50 mg Tablets, 150 mg Tablets, 200 mg Tablets, 250 mg Tablets

Recommended Reports

Sleep Disorder Markets

Pharmaceutical APIs

Therapeutic Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Armodafinil Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 50 mg Tablets
1.2.3 150 mg Tablets
1.2.4 200 mg Tablets
1.2.5 250 mg Tablets
1.3 Market by Application
1.3.1 Global Armodafinil Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
1.3.3 Shift Work Disorder (SWD)
1.3.4 Patients with Severe Hepatic Impairment
1.3.5 Geriatric Patients
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Armodafinil Market Perspective (2019-2030)
2.2 Global Armodafinil Growth Trends by Region
2.2.1 Armodafinil Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Armodafinil Historic Market Size by Region (2019-2024)
2.2.3 Armodafinil Forecasted Market Size by Region (2025-2030)
2.3 Armodafinil Market Dynamics
2.3.1 Armodafinil Industry Trends
2.3.2 Armodafinil Market Drivers
2.3.3 Armodafinil Market Challenges
2.3.4 Armodafinil Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Armodafinil by Players
3.1.1 Global Armodafinil Revenue by Players (2019-2024)
3.1.2 Global Armodafinil Revenue Market Share by Players (2019-2024)
3.2 Global Armodafinil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Armodafinil, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Armodafinil Market Concentration Ratio
3.4.1 Global Armodafinil Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Armodafinil Revenue in 2023
3.5 Global Key Players of Armodafinil Head office and Area Served
3.6 Global Key Players of Armodafinil, Product and Application
3.7 Global Key Players of Armodafinil, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Armodafinil Breakdown Data by Type
4.1 Global Armodafinil Historic Market Size by Type (2019-2024)
4.2 Global Armodafinil Forecasted Market Size by Type (2025-2030)
5 Armodafinil Breakdown Data by Application
5.1 Global Armodafinil Historic Market Size by Application (2019-2024)
5.2 Global Armodafinil Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Armodafinil Market Size (2019-2030)
6.2 North America Armodafinil Market Size by Type
6.2.1 North America Armodafinil Market Size by Type (2019-2024)
6.2.2 North America Armodafinil Market Size by Type (2025-2030)
6.2.3 North America Armodafinil Market Share by Type (2019-2030)
6.3 North America Armodafinil Market Size by Application
6.3.1 North America Armodafinil Market Size by Application (2019-2024)
6.3.2 North America Armodafinil Market Size by Application (2025-2030)
6.3.3 North America Armodafinil Market Share by Application (2019-2030)
6.4 North America Armodafinil Market Size by Country
6.4.1 North America Armodafinil Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Armodafinil Market Size by Country (2019-2024)
6.4.3 North America Armodafinil Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Armodafinil Market Size (2019-2030)
7.2 Europe Armodafinil Market Size by Type
7.2.1 Europe Armodafinil Market Size by Type (2019-2024)
7.2.2 Europe Armodafinil Market Size by Type (2025-2030)
7.2.3 Europe Armodafinil Market Share by Type (2019-2030)
7.3 Europe Armodafinil Market Size by Application
7.3.1 Europe Armodafinil Market Size by Application (2019-2024)
7.3.2 Europe Armodafinil Market Size by Application (2025-2030)
7.3.3 Europe Armodafinil Market Share by Application (2019-2030)
7.4 Europe Armodafinil Market Size by Country
7.4.1 Europe Armodafinil Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Armodafinil Market Size by Country (2019-2024)
7.4.3 Europe Armodafinil Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Armodafinil Market Size (2019-2030)
8.2 China Armodafinil Market Size by Type
8.2.1 China Armodafinil Market Size by Type (2019-2024)
8.2.2 China Armodafinil Market Size by Type (2025-2030)
8.2.3 China Armodafinil Market Share by Type (2019-2030)
8.3 China Armodafinil Market Size by Application
8.3.1 China Armodafinil Market Size by Application (2019-2024)
8.3.2 China Armodafinil Market Size by Application (2025-2030)
8.3.3 China Armodafinil Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Armodafinil Market Size (2019-2030)
9.2 Asia Armodafinil Market Size by Type
9.2.1 Asia Armodafinil Market Size by Type (2019-2024)
9.2.2 Asia Armodafinil Market Size by Type (2025-2030)
9.2.3 Asia Armodafinil Market Share by Type (2019-2030)
9.3 Asia Armodafinil Market Size by Application
9.3.1 Asia Armodafinil Market Size by Application (2019-2024)
9.3.2 Asia Armodafinil Market Size by Application (2025-2030)
9.3.3 Asia Armodafinil Market Share by Application (2019-2030)
9.4 Asia Armodafinil Market Size by Region
9.4.1 Asia Armodafinil Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Armodafinil Market Size by Region (2019-2024)
9.4.3 Asia Armodafinil Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Armodafinil Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Armodafinil Market Size by Type
10.2.1 Middle East, Africa, and Latin America Armodafinil Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Armodafinil Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Armodafinil Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Armodafinil Market Size by Application
10.3.1 Middle East, Africa, and Latin America Armodafinil Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Armodafinil Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Armodafinil Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Armodafinil Market Size by Country
10.4.1 Middle East, Africa, and Latin America Armodafinil Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Armodafinil Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Armodafinil Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Armodafinil Introduction
11.1.4 Teva Revenue in Armodafinil Business (2019-2024)
11.1.5 Teva Recent Developments
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Armodafinil Introduction
11.2.4 Mylan Revenue in Armodafinil Business (2019-2024)
11.2.5 Mylan Recent Developments
11.3 Apotex
11.3.1 Apotex Company Details
11.3.2 Apotex Business Overview
11.3.3 Apotex Armodafinil Introduction
11.3.4 Apotex Revenue in Armodafinil Business (2019-2024)
11.3.5 Apotex Recent Developments
11.4 Lupin
11.4.1 Lupin Company Details
11.4.2 Lupin Business Overview
11.4.3 Lupin Armodafinil Introduction
11.4.4 Lupin Revenue in Armodafinil Business (2019-2024)
11.4.5 Lupin Recent Developments
11.5 Sandoz
11.5.1 Sandoz Company Details
11.5.2 Sandoz Business Overview
11.5.3 Sandoz Armodafinil Introduction
11.5.4 Sandoz Revenue in Armodafinil Business (2019-2024)
11.5.5 Sandoz Recent Developments
11.6 Natco Pharma
11.6.1 Natco Pharma Company Details
11.6.2 Natco Pharma Business Overview
11.6.3 Natco Pharma Armodafinil Introduction
11.6.4 Natco Pharma Revenue in Armodafinil Business (2019-2024)
11.6.5 Natco Pharma Recent Developments
11.7 Aurobindo
11.7.1 Aurobindo Company Details
11.7.2 Aurobindo Business Overview
11.7.3 Aurobindo Armodafinil Introduction
11.7.4 Aurobindo Revenue in Armodafinil Business (2019-2024)
11.7.5 Aurobindo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Armodafinil Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of 50 mg Tablets
    Table 3. Key Players of 150 mg Tablets
    Table 4. Key Players of 200 mg Tablets
    Table 5. Key Players of 250 mg Tablets
    Table 6. Global Armodafinil Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Armodafinil Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Armodafinil Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Armodafinil Market Share by Region (2019-2024)
    Table 10. Global Armodafinil Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Armodafinil Market Share by Region (2025-2030)
    Table 12. Armodafinil Market Trends
    Table 13. Armodafinil Market Drivers
    Table 14. Armodafinil Market Challenges
    Table 15. Armodafinil Market Restraints
    Table 16. Global Armodafinil Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Armodafinil Revenue Share by Players (2019-2024)
    Table 18. Global Top Armodafinil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Armodafinil as of 2023)
    Table 19. Global Armodafinil Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Armodafinil Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Armodafinil, Headquarters and Area Served
    Table 22. Global Key Players of Armodafinil, Product and Application
    Table 23. Global Key Players of Armodafinil, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Armodafinil Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Armodafinil Revenue Market Share by Type (2019-2024)
    Table 27. Global Armodafinil Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Armodafinil Revenue Market Share by Type (2025-2030)
    Table 29. Global Armodafinil Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Armodafinil Revenue Share by Application (2019-2024)
    Table 31. Global Armodafinil Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Armodafinil Revenue Share by Application (2025-2030)
    Table 33. North America Armodafinil Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Armodafinil Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Armodafinil Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Armodafinil Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Armodafinil Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Armodafinil Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Armodafinil Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Armodafinil Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Armodafinil Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Armodafinil Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Armodafinil Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Armodafinil Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Armodafinil Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Armodafinil Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Armodafinil Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Armodafinil Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Armodafinil Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Armodafinil Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Armodafinil Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Armodafinil Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Armodafinil Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Armodafinil Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Armodafinil Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Armodafinil Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Armodafinil Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Armodafinil Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Armodafinil Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Armodafinil Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Armodafinil Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Armodafinil Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Armodafinil Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Armodafinil Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Teva Company Details
    Table 66. Teva Business Overview
    Table 67. Teva Armodafinil Product
    Table 68. Teva Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 69. Teva Recent Developments
    Table 70. Mylan Company Details
    Table 71. Mylan Business Overview
    Table 72. Mylan Armodafinil Product
    Table 73. Mylan Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 74. Mylan Recent Developments
    Table 75. Apotex Company Details
    Table 76. Apotex Business Overview
    Table 77. Apotex Armodafinil Product
    Table 78. Apotex Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 79. Apotex Recent Developments
    Table 80. Lupin Company Details
    Table 81. Lupin Business Overview
    Table 82. Lupin Armodafinil Product
    Table 83. Lupin Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 84. Lupin Recent Developments
    Table 85. Sandoz Company Details
    Table 86. Sandoz Business Overview
    Table 87. Sandoz Armodafinil Product
    Table 88. Sandoz Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 89. Sandoz Recent Developments
    Table 90. Natco Pharma Company Details
    Table 91. Natco Pharma Business Overview
    Table 92. Natco Pharma Armodafinil Product
    Table 93. Natco Pharma Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 94. Natco Pharma Recent Developments
    Table 95. Aurobindo Company Details
    Table 96. Aurobindo Business Overview
    Table 97. Aurobindo Armodafinil Product
    Table 98. Aurobindo Revenue in Armodafinil Business (2019-2024) & (US$ Million)
    Table 99. Aurobindo Recent Developments
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Armodafinil Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Armodafinil Market Share by Type: 2023 VS 2030
    Figure 3. 50 mg Tablets Features
    Figure 4. 150 mg Tablets Features
    Figure 5. 200 mg Tablets Features
    Figure 6. 250 mg Tablets Features
    Figure 7. Global Armodafinil Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Armodafinil Market Share by Application: 2023 VS 2030
    Figure 9. Obstructive Sleep Apnea (OSA) and Narcolepsy Case Studies
    Figure 10. Shift Work Disorder (SWD) Case Studies
    Figure 11. Patients with Severe Hepatic Impairment Case Studies
    Figure 12. Geriatric Patients Case Studies
    Figure 13. Armodafinil Report Years Considered
    Figure 14. Global Armodafinil Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Armodafinil Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Armodafinil Market Share by Region: 2023 VS 2030
    Figure 17. Global Armodafinil Market Share by Players in 2023
    Figure 18. Global Top Armodafinil Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Armodafinil as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Armodafinil Revenue in 2023
    Figure 20. North America Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Armodafinil Market Share by Type (2019-2030)
    Figure 22. North America Armodafinil Market Share by Application (2019-2030)
    Figure 23. North America Armodafinil Market Share by Country (2019-2030)
    Figure 24. United States Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Armodafinil Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Armodafinil Market Share by Type (2019-2030)
    Figure 28. Europe Armodafinil Market Share by Application (2019-2030)
    Figure 29. Europe Armodafinil Market Share by Country (2019-2030)
    Figure 30. Germany Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Armodafinil Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Armodafinil Market Share by Type (2019-2030)
    Figure 38. China Armodafinil Market Share by Application (2019-2030)
    Figure 39. Asia Armodafinil Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Armodafinil Market Share by Type (2019-2030)
    Figure 41. Asia Armodafinil Market Share by Application (2019-2030)
    Figure 42. Asia Armodafinil Market Share by Region (2019-2030)
    Figure 43. Japan Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Armodafinil Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Armodafinil Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Armodafinil Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Armodafinil Market Share by Country (2019-2030)
    Figure 53. Brazil Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Armodafinil Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Teva Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 60. Mylan Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 61. Apotex Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 62. Lupin Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 63. Sandoz Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 64. Natco Pharma Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 65. Aurobindo Revenue Growth Rate in Armodafinil Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart